IDEXX Labs (IDXX) EVP Williams Resigns

November 15, 2016 4:25 PM EST

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

IDEXX Laboratories, Inc. (Nasdaq: IDXX) announced that Michael J. Williams, Ph.D., Executive Vice President, is departing from the Company in February of next year and stepping down from his current role in November 2016. Dr. Williams has been Executive Vice President since 2012 and has been employed by the Company since 2003.

"I want to thank Michael for his fourteen years of leadership at IDEXX. From his early contributions in building our in-house chemistry franchise, to leading our global VetLabĀ® business, Michael has supported great innovation in our product portfolio. With his transition to lead our International business, Michael has spearheaded an ambitious growth agenda," said Jonathan Ayers, the Company's Chairman and Chief Executive Officer. "I look forward to following Michael's continued success as he begins a new, entrepreneurial chapter of his career."

Kathy Turner, Corporate Vice President, will take responsibility for IDEXX's Companion Animal Group (CAG) businesses in our international regions outside of the Americas. "Kathy has developed a strong record of international leadership, overseeing accelerating growth in our companion animal business in the regions of Europe, Middle East and Africa over the past few years," said Ayers.

Olivier te Boekhorst, Corporate Vice President, will add the Water business to his responsibilities, which currently include our Livestock Poultry and Dairy business, the IDEXX Latin America region and OPTI Medical. "Olivier has displayed strong leadership overseeing growth across a range of IDEXX businesses, and will build on our momentum in our Water business," continued Ayers.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Changes, Management Comments

Add Your Comment